论文部分内容阅读
目的观察格列吡嗪控释片对2型糖尿病患者血糖控制的临床效果。方法选取医院2014年2月-2015年2月收治的2型糖尿病患者100例,随机分为观察组和对照组各50例,对照组采用格列吡嗪片治疗,观察组采用格列吡嗪控释片治疗,科学评估2组患者血糖控制效果。结果观察组总有效率为94.00%高于对照组的84.00%(P<0.05),观察组2h PG、FPG、Hb Alc水平较对照组更低,差异均有统计学意义(P<0.05)。结论在2型糖尿病治疗过程中,格列吡嗪控释片有利于控制血糖,不良反应少,安全可靠,值得临床推广应用。
Objective To observe the clinical effect of glipizide controlled-release tablets on glycemic control in type 2 diabetic patients. Methods A total of 100 patients with type 2 diabetes admitted to our hospital from February 2014 to February 2015 were randomly divided into observation group (50 cases) and control group (50 cases). The control group was treated with glipizide tablets. The observation group was treated with glipizide Controlled release tablets treatment, scientific assessment of two groups of patients with glycemic control. Results The total effective rate was 94.00% in observation group and 84.00% in control group (P <0.05). The levels of PG, FPG and Hb Alc in observation group at 2h were lower than those in control group (P <0.05). Conclusion In the treatment of type 2 diabetes, glipizide controlled-release tablets are good for controlling blood sugar with few adverse reactions, which are safe and reliable and worthy of clinical application.